Life Healthcare Group Limited (0928.HK)
HKD 0.05
(-7.69%)
HKD 0.05
(-7.69%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -32.31 Million | -134.47 Million | 96.86 Million | -181.34 Million | 173.58 Million | -54.76 Million |
| Net Income | 15.81 Million | -25.19 Million | -34.45 Million | -4.58 Million | -24.85 Million | -118.85 Million |
| Depreciation & Amortization | 3.6 Million | 4.04 Million | 1.54 Million | 3.97 Million | 7.4 Million | 7.11 Million |
| Deferred income taxes | - | - | 97.77 Million | -203.08 Million | 162.67 Million | -9.29 Million |
| Stock-based compensation | - | - | 2.09 Million | 2.09 Million | 2.09 Million | 2.09 Million |
| Change in working capital | -60.46 Million | -131.44 Million | 102.96 Million | -193.54 Million | 179.33 Million | 7.19 Million |
| Other non-cash items | 85.42 Million | 18.11 Million | -73.05 Million | 213.8 Million | -153.07 Million | 56.97 Million |
| Investing Cash Flow | 1000.00 | 94.85 Million | -67.82 Million | -34.45 Million | 5000.00 | 15.63 Million |
| Investments in PPE | - | -214 Thousand | -13 Thousand | - | - | -1.52 Million |
| Acquisitions | - | 60.91 Million | -67.81 Million | -109 Thousand | 5000.00 | 17.08 Million |
| Investment purchases | - | -1.71 Million | -67.81 Million | -34.34 Million | - | - |
| Sales/Maturities of investments | - | 96.78 Million | 135.62 Million | - | - | - |
| Other Investing Activities | 1000.00 | -60.91 Million | -67.8 Million | -34.11 Million | 486 Thousand | 70 Thousand |
| Financing Cash Flow | 17.38 Million | 27.4 Million | -830 Thousand | 28.28 Million | -1.9 Million | 17.25 Million |
| Debt repayment | -1.28 Million | -2.5 Million | -807 Thousand | -932 Thousand | -1.39 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 18.84 Million | 26.36 Million | - | 29.28 Million | - | 17.25 Million |
| Other Financing Activities | 18.66 Million | 3.53 Million | -23 Thousand | -63 Thousand | -513 Thousand | 17.25 Million |
| Accounts receivables | -16.66 Million | -117.54 Million | 40.71 Million | -115.36 Million | 138.25 Million | 2.79 Million |
| Accounts payables | 22.27 Million | -13.91 Million | 8.08 Million | -23.5 Million | 39.55 Million | 23.17 Million |
| Inventory | -75.1 Million | 9000.00 | 54.17 Million | -54.17 Million | 1.77 Million | 4.4 Million |
| Other working capital | 9.03 Million | -3.44 Million | 22.64 Million | -509 Thousand | -247 Thousand | -23.17 Million |
| Cash at beginning of period | 17.78 Million | 37.4 Million | 8.57 Million | 187.57 Million | 21.06 Million | 49 Million |
| Cash at end of period | 473 Thousand | 17.78 Million | 37.4 Million | 8.57 Million | 187.57 Million | 21.06 Million |
| Capital Expenditure | - | -214 Thousand | -13 Thousand | - | - | -1.52 Million |
| Effect of forex changes on cash | -2.38 Million | -7.39 Million | 621 Thousand | 8.5 Million | -5.17 Million | -6.06 Million |
| Net cash flow / Change in cash | -17.31 Million | -19.61 Million | 28.82 Million | -179 Million | 166.51 Million | -27.93 Million |
| Free Cash Flow | -32.31 Million | -134.69 Million | 96.85 Million | -181.34 Million | 173.58 Million | -56.28 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 | 2022 FY | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 14.12 Million | 15.81 Million | 1.69 Million | -23.93 Million | -25.19 Million | -1.26 Million |
| Depreciation & Amortization | 1.48 Million | 3.6 Million | 2.12 Million | 3.23 Million | 4.04 Million | 809 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -91.77 Million | -60.46 Million | - | -117.53 Million | -131.44 Million | - |
| Other non-cash items | 60.9 Million | 85.42 Million | -20.87 Million | -66.02 Million | 18.11 Million | -39.22 Million |
| Investing Cash Flow | 1000.00 | 1000.00 | 17.78 Million | -303 Thousand | 94.85 Million | 95.16 Million |
| Investments in PPE | - | - | - | -214 Thousand | -214 Thousand | - |
| Acquisitions | - | - | - | 87 Thousand | 60.91 Million | - |
| Investment purchases | - | - | - | -55 Thousand | -1.71 Million | -1.65 Million |
| Sales/Maturities of investments | - | - | - | -34 Thousand | 96.78 Million | 96.82 Million |
| Other Investing Activities | 1000.00 | 1000.00 | - | -87 Thousand | -60.91 Million | 95.17 Million |
| Financing Cash Flow | 18.35 Million | 17.38 Million | -964 Thousand | 1.39 Million | 27.4 Million | 26 Million |
| Debt repayment | - | -1.28 Million | -964 Thousand | -2.5 Million | -2.5 Million | -314 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 18.84 Million | 18.84 Million | - | - | 26.36 Million | 26.36 Million |
| Other Financing Activities | 18.35 Million | 18.66 Million | -964 Thousand | 1.39 Million | 3.53 Million | 26.31 Million |
| Accounts receivables | -20.1 Million | -16.66 Million | - | -114.1 Million | -117.54 Million | - |
| Accounts payables | - | 22.27 Million | - | - | -13.91 Million | - |
| Inventory | -75.1 Million | -75.1 Million | - | 9000.00 | 9000.00 | - |
| Other working capital | 3.44 Million | 9.03 Million | - | -3.44 Million | -3.44 Million | - |
| Cash at beginning of period | 301 Thousand | 17.78 Million | 17.78 Million | 112.15 Million | 37.4 Million | 37.4 Million |
| Cash at end of period | 473 Thousand | 473 Thousand | 301 Thousand | 17.78 Million | 17.78 Million | 112.15 Million |
| Capital Expenditure | - | - | - | -214 Thousand | -214 Thousand | - |
| Effect of forex changes on cash | -2.91 Million | -2.38 Million | 537 Thousand | -2.27 Million | -7.39 Million | -5.12 Million |
| Net cash flow / Change in cash | 172 Thousand | -17.31 Million | -17.48 Million | -94.36 Million | -19.61 Million | 74.75 Million |
| Free Cash Flow | -15.26 Million | -32.31 Million | -17.05 Million | -93.4 Million | -134.69 Million | -41.29 Million |
PPE
MEK
CGBSW
1452
5244
NFC